AGER and chronic kidney disease: The activation of RAGE by AGEs and other ligands has led to the attenuation of inflammatory response, oxidative stress, and apoptosis, which may have contributed to a variety of microvascular and macrovascular complications [40] in diabetes and chronic kidney diseases [9].